“…Because of reports that administration of Rh immune globulin (RhIG) might reverse weak Rh immunization [1][2][3], the Rh Laboratory reviewed its experience, from 1969 to 1977, with a clinical trial of attempts to suppress weak primary Rh immunization (an Rh antibody initially detectable only by a two-stage papain-treated red cell technique (P2) or detectable by P2 and very weakly, at or after 6 min, by a sensitive, timed, indirect antiglobulin technique (IDAT) [4]. We compared the results of the clinical trial with the course of Rh immunization in 2 other groups of Rh-negative women, initially presenting with weak Rh antibodies which met the same criteria [4] ; all women followed from 1944 to 1967 in the pre-Rh prophylaxis era, and all women followed from 1968 to 1983 who were given RhIG at 28 weeks' gestation (300 pg i.m.…”